Bayer settles another wave of Roundup claims ahead of Monday’s trial in St. Louis | local business

ST. LOUIS – Bayer reached another settlement on Thursday to settle a collection of claims that its weed killer Roundup caused cancer – and avoided a trial that was due to start next week in St. Louis.

The deal shatters what is nearly the first attempt of its kind to reach the hometown of Monsanto, the agribusiness and biotech giant headquartered in the St. Louis area until its 2018 acquisition by Bayer, which was still a big local maintains a presence.

Monsanto developed Roundup in 1970 and retained the patent on the chemical until it expired in 2000. The legal obligations attached to the product — and claims about its cancer risks — have now been taken over by Bayer and have cost the German company billions in regulatory payouts and billions more in diminished stock value. In 2020, for example, the company settled the bulk of US Roundup lawsuits for nearly $10 billion.

The specific terms of Thursday’s settlement are confidential, Bayer said.

The new agreement addresses a lawsuit first filed in 2017 that involved dozens of U.S. plaintiffs — including St. Louis County resident and lead plaintiff Earl Neal, who said he was exposed to Roundup when he worked for the St. Louis City Parks Department and St. Louis City Forestry Department in the 1990s.

People also read…

  • The St. Louis restaurant defends itself against the “influencer” from Los Angeles and hits nerves
  • Pujols, who will start on opening day for Cardinals, announces he will file for divorce
  • BenFred: Shildt reopens Cardinal’s wounds a week after opening day
  • Cardinals notebook: Pujols, on the day he is named opening day starter, says he will file for divorce
  • Husband and boyfriend mourn two “incredibly close” sisters killed in shooting near Collinsville
  • Conservative-backed school board candidates win in Rockwood, St. Charles County
  • Cardinals’ leadoff man and DH questions answered; others stay
  • Prosecutor says new video proves St. Louis police lied about carjack attempt
  • Wainwright, Schumaker make prank pact (or is it an April Fool’s joke?) after years of mischievous antics
  • The family is mourning the deaths of St. Louis cousins, 12 and 14, who were shot to death at a downtown birthday party
  • The Mayor of St. Louis signs legislation allowing voluntary reparation donations as a “first step.”
  • Feds: Napleton’s auto dealership raised hidden fees and increased rates for black customers
  • Former Cardinals manager La Russa staunchly defends former manager Shildt
  • Sheena Greitens accuses ex-gov. Eric Greitens on starting a “campaign to destroy my reputation”
  • Editorial: Evidence of Russian war crimes mounts, but is Putin getting the message?

Neal and other plaintiffs in the case alleged that their use of Roundup — whether at home, at work, and on farms — caused non-Hodgkin’s lymphoma and sought damages arising from “its unreasonably dangerous and defective nature.” of the product and “wrong” would constitute conduct” by Monsanto, per their original legal complaint.

“We are pleased that the Neal case has been resolved on reasonable terms as part of our continued work to resolve the Roundup litigation,” Bayer said in a statement.

As of Thursday, the lawsuit had remained on track for a trial in St. Louis, even as Bayer reached settlements in other Roundup cases across the country.

The new agreement comes practically on the eve of the trial, which was due to start on Monday. It mirrors developments in other cases, which have also dodged trials when they were about to face a jury. For example, in January 2020, another case that was about to reach a courtroom in St. Louis was pushed back to the same day opening statements were scheduled to take place so settlement talks could continue.

In an earnings call last month, Bayer said 107,000 of approximately 138,000 Roundup personal injury lawsuits — about 75% — have been resolved or deemed ineligible.

An attorney for the plaintiffs in the case did not respond to a request for comment.

Leave a Comment